Embriopatía por isotretinoína: Un daño evitable

Author	dc.contributor.author	Troncoso Sch., Mónica
Author	dc.contributor.author	Rojas H., Carla	es_CL
Author	dc.contributor.author	Bravo Castro, Eduardo	es_CL
Admission date	dc.date.accessioned	2010-01-22T14:01:49Z
Available date	dc.date.available	2010-01-22T14:01:49Z
Publication date	dc.date.issued	2008-06
Cita de ítem	dc.identifier.citation	REVISTA MEDICA DE CHILE, Volume: 136, Issue: 6, Pages: 763-766, 2008	en_US
Identifier	dc.identifier.issn	0034-9887
Identifier	dc.identifier.uri	https://repositorio.uchile.cl/handle/2250/128288
Abstract	dc.description.abstract	Retinoic acid is a widely used drug in the treatment of cystic acne. It has teratogenic effects that depend on the gestational period in which it is used. We report a seven months old female whose mother was exposed to retinoic acid in both pregestational and gestational periods. She had a retardation of psychomotor development and a brain MRI showed frontal atrophy and a malformation of the posterior fossa. We discuss the mechanisms of the teratogenic effects of retinoic acid	en_US
Lenguage	dc.language.iso	es	en_US
Publisher	dc.publisher	SOC MEDICA SANTIAGO	en_US
Keywords	dc.subject	Abnormalities, drug-induced	en_US
Título	dc.title	Embriopatía por isotretinoína: Un daño evitable	en_US
Document type	dc.type	Artículo de revista